S9 c dipyrone monohydrate relief from fever and pain S10 a guaifenesin guaifenesin increases the elimination of secretions from the respiratory tract and facilitates, expectoration S11 b bromopride stimulates digestive tract movement S12 d ranitidine hydrochloride treats diseases associated with increased gastric secretion S13 mikania glomerata phytotherapeutic product that associates expectorant activity with antitussive activity S14 dipyrone monohydrate used in the treatment of painful manifestations and fever S15 prednisolone sodium phosphate acts against inflammatory processes, including inflammatory processes in the joints and allergic processes S16 e ascorbic acid vitamin supplement S17 cloperastine phendizoate symptomatic therapy of all forms of cough a Adult and pediatric syrup (children over 2 years of age); b oral solution for adult and pediatric use (children over 1 year of age); c oral solution for adult and pediatric use (children over 3 months of age); d pediatric use above 1 month of age; e adult and pediatric use (above 12 years of age).
Reference syrup cut (first dimension)
Mint essence in 1D Figure S1 . Mint essence.
Reference syrup (1D) Figure S2 . Transfer (heart-cut) of the ethanol peak to the second dimension (GC/MS).
Analytical validation (second dimension)
Selectivity Figure S3 . Efficiency in the separation of ethyl and isopropyl alcohols in GC/MS. 
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